SR-A and SREC-I are Kupffer and Endothelial cell receptors for helper-dependent adenoviral vectors

Molecular Therapy

Volumn 21, Issue 4, 2013, Pages 767-774

  Piccolo, Pasquale ^a   Vetrini, Francesco ^b   Mithbaokar, Pratibha ^a   Grove, Nathan C ^b   Bertin, Terry ^b   Palmer, Donna ^b   Ng, Philip ^b   Brunetti Pierri, Nicola ^a,c  

^a TELETHON INSTITUTE OF GENETICS AND MEDICINE TIGEM   (Italy)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CELL RECEPTOR; SCAVENGER RECEPTOR; SCAVENGER RECEPTOR A; SCAVENGER RECEPTOR EXPRESSED ON ENDOTHELIAL CELLS 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE TRANSFER; IN VITRO STUDY; IN VIVO STUDY; KUPFFER CELL; LIVER CELL; LIVER SINUSOID; MALE; MOUSE; NONHUMAN; RAT; SIGNAL TRANSDUCTION;

EID: 84878568088     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2012.287     Document Type: Article

References (50)

1. Brunetti-Pierri, N and Ng, P (2011). Helper-dependent adenoviral vectors for liver-directed gene therapy. Hum Mol Genet 20(R1): R7-13.
2. Ganesan, LP, Mohanty, S, Kim, J, Clark, KR, Robinson, JM and Anderson, CL (2011). Rapid and effcient clearance of blood-borne virus by liver sinusoidal endothelium. PLoS Pathog 7: e1002281.
3. Alemany, R, Suzuki, K and Curiel, DT (2000). Blood clearance rates of adenovirus type 5 in mice. J Gen Virol 81(Pt 11): 2605-2609.
4. Tao, N, Gao, G P, Parr, M, Johnston, J, Baradet, T, Wilson, JM et al. (2001). Sequestration of adenoviral vector by Kupffer cells leads to a nonlinear dose response of transduction in liver. Mol Ther 3: 28-35.
5. Zhang, Y, Chirmule, N, Gao, GP, Qian, R, Croyle, M, Joshi, B et al. (2001). Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages. Mol Ther 3(5 Pt 1): 697-707.
6. Smith, JS, Tian, J, Muller, J and Byrnes, AP (2004). Unexpected pulmonary uptake of adenovirus vectors in animals with chronic liver disease. Gene Ther 11: 431-438.
7. Lieber, A, He, CY, Meuse, L, Schowalter, D, Kirillova, I, Winther, B et al. (1997). The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors. J Virol 71: 8798-8807.
8. Brunetti-Pierri, N, Palmer, DJ, Beaudet, AL, Carey, KD, Finegold, M and Ng, P (2004). Acute toxicity after high-dose systemic injection of helper-dependent adenoviral vectors into nonhuman primates. Hum Gene Ther 15: 35-46.
9. Morral, N, O'Neal, WK, Rice, K, Leland, MM, Piedra, PA, Aguilar-Córdova, E et al. (2002). Lethal toxicity, severe endothelial injury, and a threshold effect with high doses of an adenoviral vector in baboons. Hum Gene Ther 13: 143-154.
10. Immonen, A, Vapalahti, M, Tyynelä, K, Hurskainen, H, Sandmair, A, Vanninen, R et al. (2004). AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma: a randomised, controlled study. Mol Ther 10: 967-972.
11. Kirn, D (2001). Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned? Gene Ther 8: 89-98.
12. Peng, Z (2005). Current status of gendicine in China: recombinant human Ad-p53 agent for treatment of cancers. Hum Gene Ther 16: 1016-1027.
13. Nemunaitis, J, Cunningham, C, Buchanan, A, Blackburn, A, Edelman, G, Maples, P et al. (2001). Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity. Gene Ther 8: 746-759.
14. Nemunaitis, J, Senzer, N, Sarmiento, S, Zhang, YA, Arzaga, R, Sands, B et al. (2007). A phase I trial of intravenous infusion of ONYX-015 and enbrel in solid tumor patients. Cancer Gene Ther 14: 885-893.
15. Koski, A, Rajecki, M, Guse, K, Kanerva, A, Ristimäki, A, Pesonen, S et al. (2009). Systemic adenoviral gene delivery to orthotopic murine breast tumors with ablation of coagulation factors, thrombocytes and Kupffer cells. J Gene Med 11: 966-977.
16. Shayakhmetov, DM, Di Paolo, NC and Mossman, KL (2010). Recognition of virus infection and innate host responses to viral gene therapy vectors. Mol Ther 18: 1422-1429.
17. Di Paolo, NC, van Rooijen, N and Shayakhmetov, DM (2009). Redundant and synergistic mechanisms control the sequestration of blood-born adenovirus in the liver. Mol Ther 17: 675-684.
18. Haisma, HJ, Kamps, JA, Kamps, GK, Plantinga, JA, Rots, MG and Bellu, AR (2008). Polyinosinic acid enhances delivery of adenovirus vectors in vivo by preventing sequestration in liver macrophages. J Gen Virol 89(Pt 5): 1097-1105.
19. Haisma, HJ, Boesjes, M, Beerens, AM, van der Strate, BW, Curiel, DT, Plüddemann, A et al. (2009). Scavenger receptor A: a new route for adenovirus 5. Mol Pharm 6: 366-374.
20. Khare, R, Chen, CY, Weaver, EA and Barry, MA (2011). Advances and future challenges in adenoviral vector pharmacology and targeting. Curr Gene Ther 11: 241-258.
21. Shayakhmetov, DM, Gaggar, A, Ni, S, Li, ZY and Lieber, A (2005). Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity. J Virol 79: 7478-7491.
22. Kalyuzhniy, O, Di Paolo, NC, Silvestry, M, Hofherr, SE, Barry, MA, Stewart, PL et al. (2008). Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo. Proc Natl Acad Sci USA 105: 5483-5488.
23. Smith, JS, Xu, Z, Tian, J, Stevenson, SC and Byrnes, AP (2008). Interaction of systemically delivered adenovirus vectors with Kupffer cells in mouse liver. Hum Gene Ther 19: 547-554.
24. Merrick, AF, Shewring, LD, Sawyer, GJ, Gustafsson, KT and Fabre, JW (1996). Comparison of adenovirus gene transfer to vascular endothelial cells in cell culture, organ culture, and in vivo. Transplantation 62: 1085-1089.
25. Hegenbarth, S, Gerolami, R, Protzer, U, Tran, PL, Brechot, C, Gerken, G et al. (2000). Liver sinusoidal endothelial cells are not permissive for adenovirus type 5. Hum Gene Ther 11: 481-486.
26. Xu, Z, Tian, J, Smith, JS and Byrnes, AP (2008). Clearance of adenovirus by Kupffer cells is mediated by scavenger receptors, natural antibodies, and complement. J Virol 82: 11705-11713.
27. Khare, R, Reddy, VS, Nemerow, GR and Barry, MA (2012). Identifcation of adenovirus serotype 5 hexon regions that interact with scavenger receptors. J Virol 86: 2293-2301.
28. Smith, JS, Xu, Z and Byrnes, AP (2008). A quantitative assay for measuring clearance of adenovirus vectors by Kupffer cells. J Virol Methods 147: 54-60.
29. Brunetti-Pierri, N, Ng, T, Iannitti, DA, Palmer, DJ, Beaudet, AL, Finegold, MJ et al. (2006). Improved hepatic transduction, reduced systemic vector dissemination, and long-term transgene expression by delivering helper-dependent adenoviral vectors into the surgically isolated liver of nonhuman primates. Hum Gene Ther 17: 391-404.
30. Brunetti-Pierri, N, Stapleton, GE, Palmer, DJ, Zuo, Y, Mane, VP, Finegold, MJ et al. (2007). Pseudo-hydrodynamic delivery of helper-dependent adenoviral vectors into non-human primates for liver-directed gene therapy. Mol Ther 15: 732-740.
31. Manickan, E, Smith, JS, Tian, J, Eggerman, TL, Lozier, JN, Muller, J et al. (2006). Rapid Kupffer cell death after intravenous injection of adenovirus vectors. Mol Ther 13: 108-117.
32. de Winther, MP, Gijbels, MJ, van Dijk, KW, van Gorp, PJ, suzuki, H, Kodama, T et al. (1999). Scavenger receptor defciency leads to more complex atherosclerotic lesions in APOE3Leiden transgenic mice. Atherosclerosis 144: 315-321.
33. Beauvillain, C, Meloni, F, Sirard, JC, Blanchard, S, Jarry, U, Scotet, M et al. (2010). The scavenger receptors SRA-1 and SREC-I cooperate with TLR2 in the recognition of the hepatitis C virus non-structural protein 3 by dendritic cells. J Hepatol 52: 644-651.
34. Hölzl, MA, Hofer, J, Kovarik, JJ, Roggenbuck, D, Reinhold, D, Goihl, A et al. (2011). The zymogen granule protein 2 (GP2) binds to scavenger receptor expressed on endothelial cells I (SREC-I). Cell Immunol 267: 88-93.
35. Tamura, Y, Osuga, J, Adachi, H, Tozawa, R, Takanezawa, Y, Ohashi, K et al. (2004). Scavenger receptor expressed by endothelial cells I (SREC-I) mediates the uptake of acetylated low density lipoproteins by macrophages stimulated with lipopolysaccharide. J Biol Chem 279: 30938-30944.
36. Suzuki, M, Cela, R, Clarke, C, Bertin, TK, Mouriño, S and Lee, B (2010). Large-scale production of high-quality helper-dependent adenoviral vectors using adherent cells in cell factories. Hum Gene Ther 21: 120-126.
37. Daugherty, A, Whitman, SC, Block, AE and Rateri, DL (2000). Polymorphism of class A scavenger receptors in C57BL/6 mice. J Lipid Res 41: 1568-1577.
38. Snoeys, J, Mertens, G, Lievens, J, van Berkel, T, Collen, D, Biessen, EA et al. (2006). Lipid emulsions potently increase transgene expression in hepatocytes after adenoviral transfer. Mol Ther 13: 98-107.
39. Kawabata, K, Takakura, Y and Hashida, M (1995). The fate of plasmid DNA after intravenous injection in mice: involvement of scavenger receptors in its hepatic uptake. Pharm Res 12: 825-830.
40. Platt, N and Gordon, S (2001). Is the class A macrophage scavenger receptor (SR-A) multifunctional?-The mouse's tale. J Clin Invest 108: 649-654.
41. Murphy, JE, Tedbury, PR, Homer-Vanniasinkam, S, Walker, JH and Ponnambalam, S (2005). Biochemistry and cell biology of mammalian scavenger receptors. Atherosclerosis 182: 1-15.
42. Konz, JO, Livingood, RC, Bett, AJ, Goerke, AR, Laska, ME and Sagar, SL (2005). Serotype specifcity of adenovirus purifcation using anion-exchange chromatography. Hum Gene Ther 16: 1346-1353.
43. Areschoug, T and Gordon, S (2009). Scavenger receptors: role in innate immunity and microbial pathogenesis. Cell Microbiol 11: 1160-1169.
44. Facciponte, JG, Wang, XY and Subjeck, JR (2007). Hsp110 and Grp170, members of the Hsp70 superfamily, bind to scavenger receptor-A and scavenger receptor expressed by endothelial cells-I. Eur J Immunol 37: 2268-2279.
45. Khare, R, May, SM, Vetrini, F, Weaver, EA, Palmer, D, Rosewell, A et al. (2011). Generation of a Kupffer cell-evading adenovirus for systemic and liver-directed gene transfer. Mol Ther 19: 1254-1262.
46. Mok, H, Palmer, DJ, Ng, P and Barry, MA (2005). Evaluation of polyethylene glycol modifcation of frst-generation and helper-dependent adenoviral vectors to reduce innate immune responses. Mol Ther 11: 66-79.
47. Green, NK, Herbert, CW, Hale, SJ, Hale, AB, Mautner, V, Harkins, R et al. (2004). Extended plasma circulation time and decreased toxicity of polymer-coated adenovirus. Gene Ther 11: 1256-1263.
48. Palmer, D and Ng, P (2003). Improved system for helper-dependent adenoviral vector production. Mol Ther 8: 846-852.
49. Warren, JC, Rutkowski, A and Cassimeris, L (2006). Infection with replication-defcient adenovirus induces changes in the dynamic instability of host cell microtubules. Mol Biol Cell 17: 3557-3568.
50. Brunetti-Pierri, N, Palmer, DJ, Mane, V, Finegold, M, Beaudet, AL and Ng, P (2005). Increased hepatic transduction with reduced systemic dissemination and proinfammatory cytokines following hydrodynamic injection of helper-dependent adenoviral vectors. Mol Ther 12: 99-106.